Constellium N.V (CSTM) skyrockets 118.56% since hitting worst price of $4.85

Constellium N.V (NYSE:CSTM) is now up 118.56% compared to a 12-month low of $4.85. We have seen the price to move -5.36% lower and get settled at $10.6 on 10/10/2017. This company shares are -6.89% up from its target price of $9.87 and the current market capitalization stands at $1.13B. The recent change has given its price a 3.46% lead over SMA 50 and -9.4% deficit over its 52-week high. The stock witnessed -1.4% declines, 30.86% gains and 76.67% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found CSTM’s volatility during a week at 4.53% and during a month it has been found around 4.43%.

Constellium N.V (CSTM) Top Holders

Institutional investors currently hold around $679 million or 72.8% in CSTM stock. Look at its top three institutional owners. Vaughan Nelson Investment Management, L.P. owns $63.8 million in Constellium N.V, which represents roughly 5.65% of the company’s market cap and approximately 9.4% of the institutional ownership. Similar statistics are true for the second largest owner, D. E. Shaw & Co., Inc., which owns 5,235,875 shares of the stock are valued at $58.64 million. The third largest holder is Jennison Associates Llc, which currently holds $41.71 million worth of this stock and that ownership represents nearly 3.69% of its market capitalization.

Constellium N.V 13F Filings

At the end of June reporting period, 59 institutional holders increased their position in Constellium N.V (NYSE:CSTM) by some 8,986,197 shares, 59 decreased positions by 13,440,447 and 21 held positions by 38,192,668. That puts total institutional holdings at 60,619,312 shares, according to SEC filings. The stock grabbed 17 new institutional investments totaling 4,688,293 shares while 19 institutional investors sold out their entire positions totaling 5,956,635 shares.

Constellium N.V (CSTM) Analyst Guide

Several analysts have released their opinion on Constellium N.V (NYSE:CSTM), with 2 analysts believing it is a strong buy. Whereas 4 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 2.33 average brokerage recommendation.

Previous articlexG Technology, Inc. (XGTI) now has -64.95 deficit over its 52-week high
Next articleHow Ocera Therapeutics, Inc. (OCRX) Is Trading Compared to Moving Averages?